« Back
Home /
Omipalisib (GSK2126458, GSK458)

Omipalisib (GSK2126458, GSK458)

Item no.	V0121-250mg
Manufacturer	InvivoChem LLC
CASRN	1086062-66-9
Amount	250 mg
Quantity options	100 mg 10 mg 25 mg 500 mg 50 mg 5 mg
Category	Reagents & Chemicals Molecules
Type	Biochemicals
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Description	InvivoChem Cat #:V0121CAS #:1086062-66-9Purity >=98% Description: Omipalisib (also called GSK-2126458, GSK-458), a pyridylsulfonamide analog, is a potent, highly selective and orally bioavailable small-molecule inhibitor of phosphatidylinositol 3-kinase (PI3K) p110alpha/beta/delta/gamma with potential anticancer activity. It is a dual PI3K/mToR Inhibitor that also inhibits mTORC1/2 with Ki values of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM in cell-free assays, respectively. Omipalisib is a new investigational PI3K/mToR Inhibitor developed by GSK-Glaxo SmithKline and is currently undergoing clinical trials for cancer treatment. Description: Description: Omipalisib (also called GSK-2126458, GSK-458), a pyridylsulfonamide analog, is a potent, highly selective and orally bioavailable small-molecule inhibitor of phosphatidylinositol 3-kinase (PI3K) p110alpha/beta/delta/gamma with potential anticancer activity. It is a dual PI3K/mToR Inhibitor that also inhibits mTORC1/2 with Ki values of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM in cell-free assays, respectively. Omipalisib is a new investigational PI3K/mToR Inhibitor developed by GSK-Glaxo SmithKline and is currently undergoing clinical trials for cancer treatment.pyridylsulfonamide analog, phosphatidylinositol 3-kinase (PI3K) OmipalisibPI3K/mToR Inhibitor References: Mol Cancer Ther. 2012 Apr; 11(4):909-20; ACS Med Chem Lett. 2010 Jan 19; 1(1):39-43. References: References:

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 250 mg

available

Delivery expected until 10/2/2025

Express Delivery: Save 6 days

Compare

Add to wishlist

Get an offer